BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8775973)

  • 1. Enterococcus faecalis cytolysin and lactocin S of Lactobacillus sake.
    Gilmore MS; Skaugen M; Nes I
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):129-38. PubMed ID: 8775973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic.
    Booth MC; Bogie CP; Sahl HG; Siezen RJ; Hatter KL; Gilmore MS
    Mol Microbiol; 1996 Sep; 21(6):1175-84. PubMed ID: 8898386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Enterococcus faecalis cytolysin determinant and its relationship to those encoding lantibiotics.
    Bogie CP; Hancock LE; Gilmore MS
    Dev Biol Stand; 1995; 85():627-34. PubMed ID: 8586241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lantibiotic gene clusters and encoded proteins.
    Siezen RJ; Kuipers OP; de Vos WM
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):171-84. PubMed ID: 8775977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organization and expression of a gene cluster involved in the biosynthesis of the lantibiotic lactocin S.
    Skaugen M; Abildgaard CI; Nes IF
    Mol Gen Genet; 1997 Feb; 253(6):674-86. PubMed ID: 9079878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants.
    Gilmore MS; Segarra RA; Booth MC; Bogie CP; Hall LR; Clewell DB
    J Bacteriol; 1994 Dec; 176(23):7335-44. PubMed ID: 7961506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin.
    Ryan MP; McAuliffe O; Ross RP; Hill C
    Lett Appl Microbiol; 2001 Feb; 32(2):71-7. PubMed ID: 11169046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lantibiotics produced by lactic acid bacteria: structure, function and applications.
    Twomey D; Ross RP; Ryan M; Meaney B; Hill C
    Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):165-85. PubMed ID: 12369187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells.
    Coburn PS; Gilmore MS
    Cell Microbiol; 2003 Oct; 5(10):661-9. PubMed ID: 12969372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of lantibiotic biosynthesis.
    Jack R; Bierbaum G; Heidrich C; Sahl HG
    Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island.
    Shankar N; Coburn P; Pillar C; Haas W; Gilmore M
    Int J Med Microbiol; 2004 Apr; 293(7-8):609-18. PubMed ID: 15149038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique peptide modifications involved in the biosynthesis of lantibiotics.
    Jack RW; Sahl HG
    Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships of the Enterococcal Cytolysin.
    Rahman IR; Sanchez A; Tang W; van der Donk WA
    ACS Infect Dis; 2021 Aug; 7(8):2445-2454. PubMed ID: 34265205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids.
    Lohans CT; Li JL; Vederas JC
    J Am Chem Soc; 2014 Sep; 136(38):13150-3. PubMed ID: 25207953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transposition in Lactobacillus sake and its abolition of lactocin S production by insertion of IS1163, a new member of the IS3 family.
    Skaugen M; Nes IF
    Appl Environ Microbiol; 1994 Aug; 60(8):2818-25. PubMed ID: 7521995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin.
    Coburn PS; Hancock LE; Booth MC; Gilmore MS
    Infect Immun; 1999 Jul; 67(7):3339-47. PubMed ID: 10377111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the gene cluster involved in production and immunity of the peptide antibiotic AS-48 in Enterococcus faecalis.
    Martínez-Bueno M; Valdivia E; Gálvez A; Coyette J; Maqueda M
    Mol Microbiol; 1998 Jan; 27(2):347-58. PubMed ID: 9484890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide.
    Skaugen M; Nissen-Meyer J; Jung G; Stevanovic S; Sletten K; Inger C; Abildgaard M; Nes IF
    J Biol Chem; 1994 Nov; 269(44):27183-5. PubMed ID: 7961627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lantibiotics and their pre-peptides.
    Nes IF; Tagg JR
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):89-97. PubMed ID: 8775969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.